Ally Biotech, a provider of leading-edge bioactive delivery solutions for cannabinoids based in Payson, Arizona, announced its patent-pending Lipofusion delivery technology has entered the Arizona market. The company recently finalized a manufacturing partnership with vertically integrated cannabis operation Desert Medical Campus, Inc., doing business as Uncle Herbs Medibles.
Ally Biotech brings next generation oral delivery technologies to the cannabinoid market, empowering brands to become industry gamechangers.
Through the partnership, Ally Biotech will utilize its exclusive nanoliposomal technology to manufacture water soluble products under the Desert Medical Campus license. Specializing in liposomal encapsulation, Ally Biotech’s raw material protects bioactives from degradation in the digestive system and provides effective and increased absorption on the cellular level.
Together, Ally Biotech and Desert Medical Campus will collaborate on new product development and highly bioavailable custom formulations including an original line of flavored shots.
Differing from conventional nanoemulsion techniques, Ally Biotech’s patent-pending Lipofusion delivery matrix marks the intersection of nanotechnology and liposomal science.
“Desert Medical Campus is known for pioneering new technologies and bringing first-of-its-kind products to market,” stated Pam Donner, COO of Desert Medical Campus, “By aligning with Ally Biotech, we will continue to solidify our brand portfolio as a true differentiator in the Arizona market.”
Established in 2013, Desert Medical Campus is home to a market-leading cannabis soft gel capsule operation that brought the first THC-infused gel caps to dispensary shelves under its Chill Pill Collection.
Ally Biotech is already in the final stages of manufacturing raw material for a new Chill Pill in a powder tablet. Desert Medical Campus plans to launch these products in Q4 2021.